4//SEC Filing
Jabbour Jerome D 4
Accession 0001493152-21-000133
CIK 0001582554other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 6:30 PM ET
Size
5.6 KB
Accession
0001493152-21-000133
Insider Transaction Report
Form 4
Jabbour Jerome D
DirectorPresident and CEO
Transactions
- Award
Stock option (right to buy)
2021-01-01+1,600,000→ 1,600,000 totalExercise: $1.36Exp: 2030-12-31→ Common Stock (1,600,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on January 1, 2022 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on February 1, 2022.
Documents
Issuer
Matinas BioPharma Holdings, Inc.
CIK 0001582554
Entity typeother
Related Parties
1- filerCIK 0001698838
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 6:30 PM ET
- Size
- 5.6 KB